QCOR Questcor Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QCOR Questcor Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Savant who wrote (43)	6/13/2012 1:43:44 PM
From: sense	Read Replies (1) of 107

And it's all still based on the market performance of the core product... A couple years back, when it was trading around $4, they were generating good cash and using it to do some work on a couple of other products. I don't think there was anything particularly earthshaking about them... but, reformulations of existing generic chemistries that would allow them to better meet some needs... Now, we're a few years farther along... and with adoption of the core product for more uses, the cash flow has been ramping toward increasing a bit... Might be time to look at QCOR more closely, again, to see what sort of potential ROI on the cash they're working on delivering... Are they still working on leveraging the resources they have created in ways that make sense ? I've been negligent in letting this thing drift this long without keeping up on the DD...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next